Self-nanoemulsifying drug delivery system of trans-cinnamic acid: Formulation development and pharmacodynamic evaluation in alloxan-induced type 2 diabetic rat model

Drug Development Research

Volumn 76, Issue 2, 2015, Pages 82-93

  Wang, Houyong ^a   Li, Qiang ^a   Deng, Wenwen ^a   Omari Siaw, E ^a   Wang, Qilong ^a   Wang, Shicheng ^a   Wang, Shengli ^a   Cao, Xia ^a   Xu, Ximing ^a   Yu, Jiangnan ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

diabetes; hyperglycemia; self nanoemulsifying drug delivery system; trans cinnamic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALLOXAN; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CINNAMIC ACID; GLUCOSE; MACROGOL 400; METFORMIN; MYRISTIC ACID ISOPROPYL ESTER; SURFACTANT; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; CINNAMIC ACID DERIVATIVE; EMULSIFYING AGENT; NANOCOMPOSITE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; GLUCOSE BLOOD LEVEL; INVESTIGATIVE PROCEDURES; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG DESIGN; PROCEDURES; WISTAR RAT;

ALLOXAN; ANIMALS; CINNAMATES; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EMULSIFYING AGENTS; HYPOGLYCEMIC AGENTS; MALE; NANOCOMPOSITES; RATS; RATS, WISTAR;

EID: 84927741008     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21244     Document Type: Article

References (41)

1. Adisakwattana S, Moonsan P, Yibchok AS,. 2008. Insulin releasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 56: 7838-7844.
2. Agrawal U, Sharma R, Gupta M, Vyas SP,. 2014. Is nanotechnology a boon for oral drug delivery? Drug Discov Today 19: 10.
3. Balakumar K, Raghavan CV, Selvan NT, Prasad RH, Abdu S,. 2013. Self-nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation. Colloid Surf B 112: 337-343.
4. Cai Z, Wang Y, Zhu LJ, Liu ZQ,. 2010. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Curr Drug Metab 11: 197-207.
5. Chikhi I, Allali H, Dib MEA, Medjdoub H, Tabti B,. 2014. Antidiabetic activity of aqueous leaf extract of Atriplex halimus L. (Chenopodiaceae) in streptozotocin-induced diabetic rats. Asian Pac J Trop Dis 4: 181-184.
6. Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E,. 2007. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol 85: 837-847.
7. Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J,. 2007. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ 335: 497.
8. Fara M, La HL, Cianflone K,. 2004. Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 82: 170-190.
9. Gurusubramanian G, Roy VK,. 2014. Expression of visfatin in alloxan-induced diabetic rat testis. Acta Histochemica 116: 1462-1468.
10. He ZD, Qiao CF, Han QB, Cheng CL, Xu HX, Jiang RW,. 2005. Authentication and quantitative analysis on the chemical profile of cassia bark (cortex cinnamomi) by high-pressure liquid chromatography. J Agric Food Chem 53: 2424-2428.
11. International Diabetes Federation. Annual Report. 2013. http://www.idf.org/sites/default/files/attachments/IDF-AR2013-final.pdf.
12. Jeevana JB, Sreelakshmi K,. 2011. Design and evaluation of self-nanoemulsifying drug delivery system of flutamide. J Young Pharm 3: 4-8.
13. Kale AA, Patravale VB,. 2008. Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. AAPS PharmSciTech 9: 191-196.
14. Kalinowska M, ͆wisłocka R, Lewandowski W,. 2007. The spectroscopic (FT-IR, FT-Raman and 1H, 13C NMR) and theoretical studies of cinnamic acid and alkali metal cinnamates. J Mol Struct 834-836: 572-580.
15. Kardesler L, Buduneli N, Biyikoglu B, Cetinkalp S, Kutukculer N,. 2008. Gingival crevicular fluid PGE2, IL-1b, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clin Biochem 41: 863-868.
16. Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, Kumari S,. 2010. Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharmacogn Res 2: 258-263.
17. Kumar RS, Manickam P, Periyasamy V, Namasivayam N,. 2003. Activity of Cassia auriculata leaf extract in rats with alcoholic liver injury. J Nutr Biochem 14: 452-458.
18. Lakshmi BS, Sujatha S, Anand S, Sangeetha KN, Narayanan RB, Katiyar C,. 2009. Cinnamic acid, from the bark of Cinnamomum cassia, regulates glucose transport via activation of GLUT4 on L6 myotubes in a phosphatidylinositol 3-kinase-independent manner. J Diabetes 1: 99-106.
19. Lawrence JM, Reld J, Taylor GJ, Stirling C, Reckless PD,. 2004. The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes. Atherosclerosis 174: 141-149.
20. Lee BS, Kang MJ, Choi WS, Choi YB, Kim HS, Lee SK,. 2009. Solubilized formulation of olmesartanmedoxomil for enhancing oral bioavailability. Arch Pharm Res 32: 1629-1635.
21. Liao JC, Deng JS, Chiu CS, Hou WC, Huang SS, Shie PH,. 2012. Anti-inflammatory activities of Cinnamomum cassia constituents in vitro and in vivo. Evid-Based Compl Alt 2012: 1-12.
22. Manfredi M, McCullough MJ, Vescovi P, Al-Kaarawi ZM, Porter SR,. 2004. Update on diabetes mellitus and related oral diseases. Oral Dis 10: 187-200.
23. McConville C, Friend D,. 2013. Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781. Eur J Pharm Biopharm 83: 322-329.
24. Mei L, Zhang ZP, Zhao LG, Huang LQ, Yang XL, Tang JT,. 2013. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliver Rev 65: 880-890.
25. Murali R, Saravanan R,. 2012. Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomed Prev Nut 2: 269-275.
26. Nekkanti V, Karatgi P, Prabhu R, Pillai R,. 2010. Solid Self-microemulsifying formulation for candesartan cilexetil. AAPS PharmSciTech 11: 9-17.
27. Oryan A, Hashemnia M, Hamidi A-R, Mohammadalipour A,. 2014. Effects of hydro-ethanol extract of Citrullus colocynthis on blood glucose levels and pathology of organs in alloxan-induced diabetic rats. Asian Pac J Trop Dis 4: 125-130.
28. Patel J, Patel A, Raval M, Sheth N,. 2011. Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan. J Adv Pharm Technol Res 2: 9-16.
29. Rajesh MG, Latha MS,. 2004. Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol 91: 99-104.
30. Sendrayaperumal V, Iyyam Pillai S, Subramanian S,. 2014. Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats. Chem-Biol Interact 219: 9-17.
31. Sermkaew N, Ketjinda W, Boonme P, Phadoongsombut N, Wiwattanapatapee R,. 2013. Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculata. Eur J Pharm Sci 50: 459-466.
32. Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W, Wiwattanapatapee R,. 2010. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 76: 475-485.
33. Shakeel F, Haq N, El-Badry M, Alanazi FK, Alsarra IA,. 2013. Ultrafine super self-nanoemulsifying drug delivery system (SNEDDS) enhanced solubility and dissolution of indomethacin. J Mol Liq 180: 89-94.
34. Sierra Villar AM, Naveros BC, Calpena Campmany AC, Trenchs MA, Rocabert CB, Bellowa LH,. 2012. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharmaceut 431: 161-175.
35. Song F, Li H, Sun J, Wang S,. 2013. Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats. J Ethnopharmacol 150: 125-130.
36. Tsai CM, Sun FM, Chen YL, Hsu CL, Yen GC, Weng CJ,. 2013. Molecular mechanism depressing PMA-induced invasive behaviors in human lung adenocarcinoma cells by cis- and trans-cinnamic acid. Eur J Pharm Sci 48: 494-501.
37. Wang L, Dong J, Chen J, Eastoe J, Li X,. 2009. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci 330: 443-448.
38. Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB,. 2009. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 10: 72-182.
39. Zhang H, Zhou Q, Cao J, Wang Y,. 2013. Mechanism of cinnamic acid-induced trypsin inhibition: a multi-technique approach. Spectrochi Acta A 116: 251-257.
40. Zhang HM, Chen J, Zhou QH, Shi YQ, Wang YQ,. 2011. Study on the interaction between cinnamic acid and lysozyme. J Mol Struct 987: 7-12.
41. Zhang LP, Ji ZZ,. 1992. Synthesis, antiinflammatory and anticancer activity of cinnamic acids, their derivatives and analogues. Act Pharm Sin 27: 817-823.